Medindia
Medindia LOGIN REGISTER
Advertisement

Galil Medical Announces the Appointment of Martin J. Emerson as President and Chief Executive Officer

Wednesday, March 26, 2008 General News
Advertisement
YOKNEAM, Israel and PLYMOUTH MEETING, Pennsylvania, March 25 Galil Medical, a global cryotherapy company, todayannounced that Martin J. Emerson has been appointed President and ChiefExecutive Officer. Galil Medical is a market leader in cryotherapy technologyfor the minimally invasive treatment of cancerous and non-cancerous tumours.Mr. Emerson is an experienced and successful medical device industryexecutive, and was most recently President and CEO of American MedicalSystems (AMS). He will be replacing Chen Barir, who will continue to serve onthe Galil Medical Board of Directors.
Advertisement

Chen Barir commented, "Galil Medical is very pleased to have been able toattract an executive with the leadership experience and stature of MartyEmerson. We are confident that Marty will be able to help Galil Medicalsustain the growth that has been recorded since our December 2006reorganisation and recapitalisation financing."
Advertisement

"I am very excited to be joining Galil Medical," said Mr. Emerson. "Thecompany has developed innovative cryotherapy solutions to treat prostatecancer and renal tumours and has a promising product pipeline for the Women'sHealth and Interventional Radiology markets. I look forward to working withthe talented team to expand the opportunities for Galil Medical's industryleading technology around the globe."

Mr. Emerson has a strong track record of over 20 years of accomplishmentsin the medical device industry, most recently as President and ChiefExecutive Officer of AMS. During his tenure at AMS, he held executive rolesincluding Vice President and General Manager of International, Executive VicePresident of Global Sales and Marketing and Chief Operating Officer. Prior tojoining AMS, he held senior roles in the overseas operations for severalAmerican-based companies including Baxter International and Boston Scientific.

About Galil Medical

Galil Medical develops, manufactures and markets innovative productsutilising a proprietary cryotherapy platform that incorporates powerfulfreezing technology and revolutionary 17-gauge cryoablation needle design.Galil Medical systems enable minimally invasive, targeted ablation of benignand cancerous tumours while ensuring rapid recovery and enhanced quality oflife for patients. The Presice(TM) Cryoablation System features multi-pointthermal sensors (MTS) and advanced IceVue(TM) planning software for excellentprocedure control in treating prostate and renal cancer. The SeedNet(TM)system provides physicians with an easy-to-use cryoablation solution toprecisely ablate tumours while protecting adjacent structures.

Galil Medical is a global medical device company with offices in Yokneam,Israel; Plymouth Meeting, Pennsylvania; and London, shareholders includeThomas, McNerney & Partners, The Vertical Group, Investor Growth Capital,Elron Electronic Industries Ltd. (NASDAQ: ELRN) and RDC Rafael DevelopmentCorporation, Ltd. For more information, please visithttp://www.galilmedical.comPam Schwartz Communications Manager Galil Medical T: +972-4-909-3273 M: +972-52-625-4443 F: +972-4-959-1077 pam.schwartz@galilmedical.com

SOURCE Galil Medical
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close